Are you a man worried about losing your hair as you get older? There might soon be more prescription treatments to help stem the tide of male androgenetic alopecia (AGA), aka male pattern baldness.

On Wednesday, Cosmo Pharmaceuticals announced the results of its two phase III trials testing out the topical drug clascoterone for AGA. Compared to placebo, people on clascoterone gained back significantly more hair—with one trial showing a roughly 500% improvement in hair restoration. The results will pave the way for a potential FDA approval next year, which could make clascoterone the first truly novel treatment for pattern baldness seen in decades.

First-in-class

Male pattern baldness is primarily caused by having genes that make a person’s hair follicles overly sensitive to androgens

See Full Page